Hologic, Inc. said the Clarity HD high-resolution 3D imaging and Intelligent 2D imaging technology has received PMA approval from FDA and are now available on the 3Dimensions breast tomosynthesis system.
The first large cancer screening/early detection initiative to be launched in 2025—the NCI-funded Vanguard study of multi-cancer detection tests—has started accruing patients through nine sites across the U.S.
